889 results on '"Heneka, Michael T."'
Search Results
2. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
3. TREM1 is the new kid on the block for the aging-associated innate immune response and Alzheimer’s disease
4. Inflammatory aspects of Alzheimer’s disease
5. The endotoxin hypothesis of Alzheimer’s disease
6. Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?
7. Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition
8. Inflammasomes in neurological disorders — mechanisms and therapeutic potential
9. Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes
10. Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study
11. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
12. Exploring the ATN classification system using brain morphology
13. Innate immune activation in neurodegenerative diseases
14. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
15. Lifelong experiences as a proxy of cognitive reserve moderate the association between connectivity and cognition in Alzheimer's disease
16. Cerebral dysfunctions caused by sepsis during ageing
17. New insights into the genetic etiology of Alzheimer’s disease and related dementias
18. p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function
19. Peripheral and central immune system crosstalk in Alzheimer disease — a research prospectus
20. In vivo mechanisms of cortical network dysfunction induced by systemic inflammation
21. Deletion of the inflammatory S100-A9/MRP14 protein does not influence survival in hSOD1G93A ALS mice
22. Vaccination with (1–11)E2 in alum efficiently induces an antibody response to β-amyloid without affecting brain β-amyloid load and microglia activation in 3xTg mice
23. The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease
24. Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.
25. Inferior Frontal Sulcal Hyperintensities on Brain MRI Are Associated with Amyloid Positivity beyond Age—Results from the Multicentre Observational DELCODE Study.
26. In vivo characterization of functional states of cortical microglia during peripheral inflammation
27. Neuroimmune Connections in Aging and Neurodegenerative Diseases
28. Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease
29. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
30. Astrocyte-specific expression of interleukin 23 leads to an aggravated phenotype and enhanced inflammatory response with B cell accumulation in the EAE model
31. TREM2 modulates differential deposition of modified and non-modified Aβ species in extracellular plaques and intraneuronal deposits
32. Do infections have a role in the pathogenesis of Alzheimer disease?
33. CNS-Specific Synthesis of Interleukin 23 Induces a Progressive Cerebellar Ataxia and the Accumulation of Both T and B Cells in the Brain: Characterization of a Novel Transgenic Mouse Model
34. NLRP3 inflammasome activation drives tau pathology
35. Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer's disease—Data from three memory clinic studies
36. Silencing Apoe with divalent‐siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease.
37. In‐depth analysis of data from the RAS‐ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis.
38. Immune Activation in Alzheimer Disease.
39. Microglia heterogeneity in health and disease.
40. Inflammasome-derived cytokine IL18 suppresses amyloid-induced seizures in Alzheimer-prone mice
41. Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-β plaques: A potential role in shaping plaque pathology?
42. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial
43. Dysregulation of TLR5 and TAM Ligands in the Alzheimer’s Brain as Contributors to Disease Progression
44. Elevated levels of Secreted-Frizzled-Related-Protein 1 contribute to Alzheimer’s disease pathogenesis
45. Publisher Correction: Peripheral and central immune system crosstalk in Alzheimer disease — a research prospectus
46. Time course of dementia following sepsis in German health claims data
47. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease
48. Corrigendum: mTOR-dependent translation amplifies microglia priming in aging mice
49. Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples
50. Phosphorylation-state dependent intraneuronal sorting of Aβ differentially impairs autophagy and the endo-lysosomal system.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.